As of 2024-12-15, the Relative Valuation of Epizyme Inc (EPZM) is (22.09) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.47 USD, the upside of Epizyme Inc based on Relative Valuation is -1602.7%.
The range of the Relative Valuation is (13.75) - (23.28) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.4x - 24.1x | 17.3x |
| Forward P/E multiples | 11.1x - 18.9x | 18.5x |
| Fair Price | (13.75) - (23.28) | (22.09) |
| Upside | -1035.2% - -1683.3% | -1602.7% |
| Date | P/E |